FDA testing speedier drug development with real-time clinical trials
WASHINGTON — The Food and Drug Administration on Tuesday announced efforts to make clinical trials more efficient, starting…
20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs
Collection of sandflies, which can transmit river blindness Universal Images Group via Getty Images Occasionally I’ll go watch…
Eli Lilly’s $3.25B acquisition of Kelonia Therapeutics caps startup’s tortuous ride
Eli Lilly is spending $3.25 billion to acquire Kelonia Therapeutics, a small biotech company developing cell therapies for…
Gilead to buy cancer biotech Tubulis for more than $3B
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Terns, Merck, Gilead, Tubulis: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
SuppCo launches certification to verify actives in dietary supplements
The new program complements SuppCo’s TrustScore supplement quality rating system and builds on earlier testing initiatives, which revealed…
Ocular Therapeutix wet AMD drug Axpaxli tops Eylea in study
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Prasad overruled FDA staff to reject Moderna flu vaccine application
WASHINGTON — Top Food and Drug Administration official Vinay Prasad overruled the agency’s reviewers when he refused to accept…
Ivermectin for cancer? National Cancer Institute is ‘taking it seriously’
The National Cancer Institute, the federal research agency charged with leading the war against the nation’s second-largest killer,…
Takeda deepens AI drug discovery push with $1.7 billion Iambic deal
By Kamal Choudhury Feb 9 (Reuters) – Privately held Iambic said on Monday it has entered a multi-year…